Motif Bio Share Discussion Threads

[small crow] 19/2/2021 13:34

Not really an explanation that Scott!

[scottdavid70] 19/2/2021 13:26

Because Lumsden wanted his “one shot goal” he missed but didn’t explain why he delayed the shot and then missed an
Open goal

[bi11y ray va1entine] 19/2/2021 12:53

Why was the NDA submitted late then? I've looked but can't find any reference to it anywhere.

[scottdavid70] 19/2/2021 08:26

Be honest as to why the NDA submission was late, explain why the HARB trails were stopped and European submission halted. There was clearly something they knew to halt two very pivotal things in Motifs pipeline.

Why did you have 2 liver experts on standby if you had no idea that liver toxicity could be an issue?

Front up at the AGM post FDA decision after the Type A meeting rather than hiding behind office furniture and still asking for more in salaries that your shareholders had to rebuke. Imagine after failing to have zero conscience to do that? Could have had a chance to explain why the liver experts were on standby at the AGM if he had held it at the same time as they did the year previously.

Don’t then sit on a full salary eating up the money so you end you diluting even faster the very people you have asked to invest and then failed to deliver your promise too.

There is more but that’s for starters and shows what type of person the former CEO is and was.

[bi11y ray va1entine] 19/2/2021 08:02

Since you're the expert Scott, what would you have done differently if you'd been in charge leading up to the FDA response?

[scottdavid70] 18/2/2021 22:35

Remember Lumsden is up for a BONUS on top of all the money he has taken from you - diluted your shareholding’s - and that Bonus is directly related to a RTO that he caused by not getting Iclaprim approved- not as it should be on a sale or something beneficial for investors who have lost 90% of their INVESTMENT HERE

[scottdavid70] 18/2/2021 22:33

I see the LSE brain trust wonders when updates are coming. Read the RNS not till end of March - until then keep reading about how this company was led and how much of your money has been moved into Directors accounts in salaries despite failing to get Iclaprim approved or sold more recently

[scottdavid70] 18/2/2021 22:32

During all that time Lumsden, despite not getting iclaprim approved took full pay

[scottdavid70] 18/2/2021 22:30

Absolutely not - they had 2 liver experts on standby for the AdComm meeting but we didn’t know that.

They cancelled HARP Trials and European Submission for Iclaprim but slotted into a presentation without telling us.

They told us no clinical trials were needed in a webcast after the FDA decision but actually we needed full phase iii trials

Definitely didn’t lose my money ‘through’; my own fault and the world will hear

[philoosh] 18/2/2021 15:04

Does anyone still have shares in this? What would happen if an RTO was to take place to those with shares? I'd written this off as a balls up

[small crow] 18/2/2021 12:55

Do you think the BOD asked the FDA to refer their application for more data as a deliberate strategy?? If not, then you have nothing to say except "I lost money through my own fault and I won't stop crying about it".

[scottdavid70] 18/2/2021 12:00

No I want to make sure that no one ever forgets what went on here warts and all forever.

The names of the people involved and the scenarios that unfolded

I can’t ask a bot to put my special brand of insight on it - far too bland

[bi11y ray va1entine] 18/2/2021 10:01

You know you could set up a bot to keep reposting the same three comments every day don't you Scott, just to save you the effort?

[scottdavid70] 17/2/2021 13:32

Struck a nerve - I see you only post on Walbrook companies. Protecting the old reputation- I get that I honestly do.

Anyway just another 6 weeks till another missed deadline

[scottdavid70] 17/2/2021 08:03

The boys on LSE will be disappointed with no red dot on LSE. They only have 6 weeks of disappointment ahead before the paltry pay off for them but the gargantuan one for Lummy and Chummy Gold

[scottdavid70] 16/2/2021 22:34

Probably the 31st March is a Wednesday.

Let’s be honest we will be lucky if that does happen then - the NDA submission was late but that was just brushed aside with the “one shot at goal” but many of us feel that’s when the liver issue first truly was apparent to them.

The RTO deadline missed

They honestly have zero intimacy the shareholders which is why the review about Corporate Governance is still outstanding

The collective IQ of the rest of the shareholders is that of a peanut so they have got away with it

[chuffer2] 16/2/2021 14:59

30th of March it is then lol

[bi11y ray va1entine] 16/2/2021 14:45

The 27th January RNS says "it is currently expected that the AIM Admission Document will be published before the end of March 2021". Not at the end of March. Before.

[scottdavid70] 16/2/2021 13:53

It wounds me I am invested in a company that has investors on LSE that say they are waking up for a RNS everyday in February when the company has said it’s not coming till the end of March.

No wonder Lord Lumsden of unearned Loot has had such a easy ride with that IQ level. He must have felt like he was taking candy from a Baby when trousering that grotesque salary

[scottdavid70] 15/2/2021 08:02

By the time Lummy and Gold(en) have finished with the catastrophic consolidation and mammoth dilution even if they RTO’d with Amazon and Apple combined your shares would be worth 1/2p

They however won’t be affected as all they have to do is do the RTO to get enormous pay outs

[dafad] 15/2/2021 06:56

What if Oxford Nanopore used as a vehicle for listing!!We can dream

[scottdavid70] 15/2/2021 03:33

Who can explain the logic and expense of paying Graham Lumsden a BONUS of £100,000 based on a RTO?

He was employed to get Iclaprim approved. He failed. So surely any BONUS should be attached to a sale of Iclaprim or any benefit to shareholders and the RTO is a separate issue?

He has zero RTO experience so why is the BONUs attached to a RTO?

Answers please?